NCT05828446 (AMRIK) is a NA clinical trial of MRI in Magnetic Resonance Imaging, sponsored by Naik Vietti Violi.

Who is sponsoring NCT05828446?

NCT05828446 is sponsored by Naik Vietti Violi.

What drugs are being tested in NCT05828446?

Interventions in NCT05828446: MRI.

What condition does NCT05828446 study?

NCT05828446 studies Magnetic Resonance Imaging, Hepatocellular Carcinoma, Screening, Contrast-enhanced US.

Is NCT05828446 still recruiting?

NCT05828446 is currently recruiting now. Last updated 3 April 2025.

Last reviewed 2025-04-03 · How we verify

NCT05828446: AMRIK

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improving Hepatocellular Carcinoma Screening

Recruiting now NA Last updated 3 April 2025

What this trial tests

NA trial testing MRI in Magnetic Resonance Imaging in 330 participants. Currently enrolling.

Timeline

1 April 2023

Primary endpoint
30 April 2026

30 April 2027

Quick facts

Lead sponsor	Naik Vietti Violi
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	screening
Enrollment	330
Start date	1 April 2023
Primary completion	30 April 2026
Estimated completion	30 April 2027
Sites	1 location across Switzerland

Drugs / interventions tested

MRI — full drug profile →

Conditions studied

Magnetic Resonance Imaging — all drugs for Magnetic Resonance Imaging →
Hepatocellular Carcinoma — all drugs for Hepatocellular Carcinoma →
Screening — all drugs for Screening →
Contrast-enhanced US — all drugs for Contrast-enhanced US →

Sponsor

Naik Vietti Violi

Who can join

18 and older, any sex, with Magnetic Resonance Imaging or Hepatocellular Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a monocentric, single blind, interventional, single arm study. It is designed to compare the rates of detection of hepatocellular carcinoma (HCC) by ultrasound (US) used in clinical routine vs. abbreviated magnetic resonance imaging (AMRI). The hypothesis is that dynamic AMRI with extracellular contrast agent injection has a higher patient-level detection rate of HCC than screening US and non-contrast AMRI. Interested and eligible patients will be enrolled and undergo HCC screening rounds including US +/- contrast-enhanced US (clinical routine) and screening MRI within the same week bi-annually.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Recent advances and issues in imaging modalities for hepatocellular carcinoma surveillance.
Lee DH. · · 2025 · cited 5× · PMID 40007309 · DOI 10.17998/jlc.2025.02.16
Persisting challenges in the early detection of hepatocellular carcinoma.
Arvind A, Redmon K, Singal AG. · · 2025 · cited 3× · PMID 39943795 · DOI 10.1080/14737140.2025.2467184
Abbreviated MRI-Based Surveillance Strategies for Early Hepatocellular Carcinoma Detection.
Park HJ, Kim DW, Choi WM, Kim SY. · · 2025 · cited 1× · PMID 40502477 · DOI 10.3348/jksr.2024.0153

Verify or expand the search:

Other trials of MRI

Trials testing the same drug.

NCT02831335 — Technical Development of Multi-Parametric Renocerebral MRI · recruiting
NCT07487870 — Radiographic Evaluation of Tumor Biology During Neoadjuvant Radiotherapy for Sarcoma · NA · not yet recruiting
NCT07567053 — Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Cerebral Palsy: TMS-EEG Study · NA · not yet recruiting
NCT07537504 — Language Function Reorganization in Patients With Arteriovenous Malformations · not yet recruiting
NCT07217990 — Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer · Phase 1, PHASE2 · not yet recruiting

Other recruiting trials for Magnetic Resonance Imaging

Currently open trials in the same condition.

NCT06725550 — Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0 · NA · recruiting
NCT07138768 — Role of MRI in the Early Diagnosis and Management of Acute Stroke and Its Impact on Turnaround Time in Emergency Setting · recruiting
NCT07069452 — Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke · recruiting
NCT06509087 — The Combined Utility of Angio-CT and MRI in Managing Chronic Musculoskeletal Pain: a Prospective Study to Evaluate the E · recruiting
NCT06108089 — Novel Hypoxia Imaging for Head and Neck Cancer: Imaging Phenotype for Personalized Treatment · recruiting

Other Naik Vietti Violi trials

Trials by the same sponsor.

NCT06571981 — Conventional Ultrasound Versus Remote Ultraportable ulTrasound in the Context of Viral Hepatitis · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05828446 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Naik Vietti Violi
Last refreshed: 3 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05828446.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing